Glenmark Pharmaceuticals Limited

NSE: GLENMARKHealthcareLot size: 375

Glenmark Pharmaceuticals Limited FII & DII Activity

FII Net (₹ Cr)
+871.83Buy 16,834.53Sell 15,962.7
DII Net (₹ Cr)
+643.35Buy 17,240.9Sell 16,597.55
FII F&O Net (contracts)
+643395Index + stock futures

5-Day Flow Trend

DateFII Net (₹ Cr)DII Net (₹ Cr)
2026-10-28+871.83+643.35
2026-10-27−1462.49+2609.57
2026-10-26−1462.49+2609.57
2026-10-23+887.65+3235.36
2026-10-22−3458.70+2891.32
AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

FII cash inflow stands at ₹871.83 Cr while DII cash inflow reaches ₹643.35 Cr, indicating a net positive bias from foreign investors and a modest accumulation by domestic players across large‑cap equities. The foreign institutional investors post a sizable cash surge, especially in pharma, contrasting with the domestic institutions’ more restrained purchase pace. Overall, the market registers a bullish tilt from both categories on the day driven by supportive macro data.

Trend vs 5-Day Average

Today's FII cash outflow of –₹894.74 Cr over the past five sessions signals a reversal to net buying after a period of selling pressure. The shift aligns with easing geopolitical tensions and a softer USD index. Conversely, DII cash activity remains positive, with a five‑day average inflow of ₹2,592.03 Cr, reinforcing the domestic side’s continued accumulation trend. This reflects strong appetite for

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-10-28

Frequently Asked Questions

What is FII net buying/selling in Glenmark Pharmaceuticals Limited today?
FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹871.83 Cr (net buying) as of 2026-10-28. This market-wide figure applies to all F&O stocks including Glenmark Pharmaceuticals Limited.
What is DII activity in Glenmark Pharmaceuticals Limited today?
DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹643.35 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.
What is FII F&O net for Glenmark Pharmaceuticals Limited today?
FII net F&O position (index + stock futures combined) is +6,43,395 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.
Were there any block deals in Glenmark Pharmaceuticals Limited?
Block deal data for Glenmark Pharmaceuticals Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.
How does FII/DII data affect Glenmark Pharmaceuticals Limited stock price?
FII and DII flows are market-wide data — all F&O stocks including Glenmark Pharmaceuticals Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Glenmark Pharmaceuticals Limited's individual OI buildup type, this provides a directional framework.